MAM

MPM Asset Management Portfolio holdings

AUM $43.3M
This Quarter Return
+29.87%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$297M
AUM Growth
+$297M
Cap. Flow
+$53.9M
Cap. Flow %
18.14%
Top 10 Hldgs %
99.17%
Holding
14
New
2
Increased
Reduced
2
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
$75.8M 25.5% +5,831,253 New +$75.8M
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$75.1M 25.27% 2,413,819
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$35.6M 11.98% 1,220,672
PETX
4
DELISTED
Aratana Therapeutics, Inc.
PETX
$32.7M 11% 2,093,845 -694,320 -25% -$10.8M
TRIV
5
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$27.7M 9.31% +1,776,692 New +$27.7M
EIGR
6
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$17.1M 5.75% 1,066,774
HSTO
7
DELISTED
Histogen Inc. Common Stock
HSTO
$10.9M 3.65% 1,192,080
ALT icon
8
Altimmune
ALT
$338M
$8.95M 3.01% 6,347,614
VSTM icon
9
Verastem
VSTM
$569M
$7.4M 2.49% 816,683
PCRX icon
10
Pacira BioSciences
PCRX
$1.2B
$3.59M 1.21% 39,025
ETRM
11
DELISTED
EnteroMedics Inc.
ETRM
$1.74M 0.58% 1,113,168
SGMO icon
12
Sangamo Therapeutics
SGMO
$157M
$343K 0.12% 22,487
SVRA icon
13
Savara
SVRA
$567M
$331K 0.11% 524,853
MGNX icon
14
MacroGenics
MGNX
$112M
$69K 0.02% 3,168 -1,777,787 -100% -$38.7M